CalciMedica, Inc. (CALC) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $0.98 (+15.70%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| May 20, 2024 | Leland Gershall | Oppenheimer | $14.00 | +1324.1% |
| Nov 22, 2022 | Christopher Raymond | Raymond James | $392.00 | +39773.9% |
| May 18, 2022 | Christopher Raymond | Piper Sandler | $392.00 | +39773.9% |
Top Analysts Covering CALC
CALC vs Sector & Market
| Metric | CALC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +26957.3% | +16283.5% | +17.1% |
| P/E Ratio | -292.74 | 3.28 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2M | $2M | $2M | 4 |
| 2027-12-31 | $7M | $7M | $7M | 3 |
| 2028-12-31 | $4M | $4M | $4M | 3 |
| 2029-12-31 | $15M | $15M | $15M | 2 |
| 2030-12-31 | $22M | $22M | $22M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.61 | $-1.34 | $-1.08 | 2 |
| 2027-12-31 | $-3.48 | $-2.16 | $-0.84 | 2 |
| 2028-12-31 | $-3.54 | $-2.07 | $-0.98 | 3 |
| 2029-12-31 | $-1.99 | $-1.99 | $-1.99 | 1 |
| 2030-12-31 | $-1.56 | $-1.56 | $-1.56 | 1 |
Frequently Asked Questions
What is the analyst consensus for CALC?
The consensus among 1 analysts covering CalciMedica, Inc. (CALC) is Buy with an average price target of $266.00.
What is the highest price target for CALC?
The highest price target for CALC is $392.00, set by Christopher Raymond at Raymond James on 2022-11-22.
What is the lowest price target for CALC?
The lowest price target for CALC is $14.00, set by Leland Gershall at Oppenheimer on 2024-05-20.
How many analysts cover CALC?
1 analysts have issued ratings for CalciMedica, Inc. in the past 12 months.
Is CALC a buy or sell right now?
Based on 1 analyst ratings, CALC has a consensus rating of Buy (2.00/5) with a +26957.3% upside to the consensus target of $266.00.
What are the earnings estimates for CALC?
Analysts estimate CALC will report EPS of $-1.34 for the period ending 2026-12-31, with revenue estimated at $2M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.